PI
WST icon

PEAK6 Investments’s West Pharmaceutical WST Stock Holding History

PEAK6 Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.87M Buy
12,900
+8,300
+180% +$2.54M 0.01% 1097
2024
Q2 		$1.52M Sell
4,600
-8,500
-65% -$3M ﹤0.01% 1533
2024
Q1 		$5.18M Buy
13,100
+6,400
+96% +$2.37M 0.01% 813
2023
Q4 		$2.36M Buy
6,700
+1,200
+22% +$425K 0.01% 1382
2023
Q3 		$2.06M Sell
5,500
-1,600
-23% -$619K 0.01% 1310
2023
Q2 		$2.72M Buy
7,100
+1,500
+27% +$536K 0.01% 996
2023
Q1 		$1.94M Buy
5,600
+4,600
+460% +$1.34M 0.01% 1332
2022
Q4 		$235K Buy
1,000
+200
+25% +$47.4K ﹤0.01% 3166
2022
Q3 		$197K Sell
800
-6,300
-89% -$1.92M ﹤0.01% 3665
2022
Q2 		$2.72M Buy
7,100
+5,900
+492% +$1.92M 0.01% 1974
2022
Q1 		$493K Sell
1,200
-300
-20% -$117K ﹤0.01% 3148
2021
Q4 		$704K Sell
1,500
-5,600
-79% -$2.41M ﹤0.01% 2896
2021
Q3 		$3.01M Buy
7,100
+3,100
+78% +$1.31M 0.01% 1568
2021
Q2 		$1.44M Buy
4,000
+3,300
+471% +$1.09M ﹤0.01% 2220
2021
Q1 		$197K Sell
700
-2,900
-81% -$830K ﹤0.01% 3937
2020
Q4 		$1.02M Sell
3,600
-17,400
-83% -$4.88M ﹤0.01% 2468
2020
Q3 		$5.77M Buy
21,000
+5,300
+34% +$1.4M 0.01% 869
2020
Q2 		$3.57M Hold
15,700
– – 0.01% 1035
2020
Q1 		$2.39M Buy
+15,700
New +$2.42M 0.01% 911
2019
Q4 		– Sell
-9,500
Closed -$1.35M – 4166
2019
Q3 		$1.35M Buy
+9,500
New +$1.31M 0.01% 1547
2019
Q2 		– Sell
-6,400
Closed -$705K – 4382
2019
Q1 		$705K Buy
6,400
+5,900
+1,180% +$614K ﹤0.01% 2123
2018
Q4 		$49K Sell
500
-3,600
-88% -$391K ﹤0.01% 3643
2018
Q3 		$506K Buy
+4,100
New +$460K ﹤0.01% 2555

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Investments's WST Position: Q2 2024 in Review

PEAK6 Investments sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 2 shares — an estimated $707 sold.

PEAK6 Investments first reported a position in WST in Q4 2018 and held it in 17 quarters. The position peaked at $7.38M in Q2 2019. 776 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • PEAK6 Investments reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2 West Pharmaceutical shares in Q2 2024, an estimated $707.
  • PEAK6 Investments first reported a position in West Pharmaceutical in Q4 2018 and held it in 17 quarters.
  • PEAK6 Investments's West Pharmaceutical position peaked at $7.38M in Q2 2019.
  • 776 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.